Tel:
Fax:
Email:
Creative Biolabs

NeuroMab™ Anti-CD14 BBB Shuttle Antibody(NRZP-1022-ZP3700)

[CAT#: NRZP-1022-ZP3700]

Host Species:
Mouse
Species Reactivity:
Human
Applications:
WB; FC; ELISA; Inhib

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Applications

WB; FC; ELISA; Inhib

Relevant Diseases

Neuroinflammation
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

CD14

Official Name

CD14

Full Name

Cluster of differentiation 14

Alternative Names

IVL
Product Pictures
FuncS

Figure 1 shows the expression of recombinant IgG2/4 hybrid antibody.

(AC) Ab concentration (mg/ml; s) and Ab productivity (pg/cell/day; d) in cell culture supernatants were determined by ELISA during 12 days of fed-batch expression. Data are presented as mean and SEM for rMil2 (A; n=12), r18D11 (B; n=5) and raNIP (C; n=2). (D) 500 ng of each purified antibody was subjected to reducing or non-reducing SDS-PAGE and stained with Coomassie blue. (E) Non-reducing SDS-PAGE and immunoblotting of the same sample (10 ng) using an Ab specific for the human IgG2 hinge region.

FuncS

Figure 2 shows the functional characterization of anti-human D14 Ab r18D11.

(A) Binding of increasing concentrations of r18D11 (O), raNIP (N), 18D11 F(ab)92 (▴) or control F(ab)92 (n) to monocytes was determined by the ability of Abs to displace 10 mg/ ml Original clone 18D11 mIgG1, CD14 binding site from human whole blood. (BD) Using 100 ng/ml ultrapure LPS from E. coli O111:B4 at increasing concentrations of r18D11 (O) or the original clone 18D11 (▴). (E) Flow cytometry measurement of monocyte oxidative burst after addition of different Ab preparations to human whole blood.

FuncS

Figure 3 shows the in vitro binding of recombinant IgG2/4 hybrid antibodies to complement and Fc receptors.

Increasing concentrations of rMil2 (s), r18D11 (0) or raNIP (N) were mixed with (A) immobilized human C1q, (B) human Fcg receptor FcgRI, (C) FcgRIIa (allotype His131), (D) FcgRIIb, (E) FcgRIIIa (allotype Val158), (F) FcgRIIIb and (G, H) human (hFcRn) or (I, J) porcine FcRn (pFcRn), acidic (pH 6.0) and neutral pH (pH 7.4).

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar

The Spectrum of Stem Cell-Based Neuronal Models and Their Fit for Purpose

2:00 PM–3:00 PM EST, December 12, 2024

REGISTER NOW
Inquiry Basket
compare

Send inquiry